A triple A syndrome with neurological findings; c464G>A mutation in the AAAS gene
Ideggyógyászati szemle · 2025
DOI: 10.18071/isz.78.0207 ↗Kurz gefasst
Fallbericht in der Zeitschrift Ideggyógyászati szemle, 2025. Verfasst von Pinar Bengi Boz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Adana City Training and Research Hospital, Adana Faculty of Medicine, Health Sciences University, Adana, Turkey. Hauptthemen laut MEDLINE: Esophageal Achalasia, Adrenal Insufficiency, Nuclear Pore Complex Proteins.
Abstract (Originalsprache)
Introduction – Allgrove syndrome or triple A (3A) syndrome is a multisystem disorder classically defined as the triad of esophageal achalasia, alacrimia and adrenal insufficiency due to adrenocorticotropic hormone insensitivity. Approximately one third of patients experience neurological dysfunction, including peripheral and autonomic nervous system dysfunction, leading some authors to use the term 4A syndrome (achalasia, alacrimia, adrenal insufficiency and autonomic abnormalities). Since its first description in 1978, knowledge of its clinical and genetic features has increased; however, the current literature is limited to case reports and case reviews. Methods – A 20-year-old male patient was admitted to the clinic with the following complaints: difficulty in walking, tingling sensation in the feet and weakness of 1.5 years’ duration. He had undergone endoscopy and balloon dilatation surgery 2 years previously. Results – We performed whole exome analysis on the patient and detected the c464G>A p.(Arg155His) variant in the AAAS gene in homozygous form. It was interpreted as ‘pathogenic’ according to the ACMG 2015 criteria: homozygous pathogenic variants in this gene correspond to the phenotype ‘AchalasiaAddisonism-Alacrimia’ (OMIM:231550). Conclusion – We present this case to draw attention to the fact that patients may present with late-onset neurological findings without the classic Allgrove syndrome triad.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurology Department, Adana City Training and Research Hospital, Adana Faculty of Medicine, Health Sciences University, Adana, Turkey.
- Department of Neurology, Faculty of Medicine, Çukurova University, Adana, Turkey.
- Department of Medical Genetics, Faculty of Medicine, Çukurova University, Adana, Turkey.
ORCID-Profile: Pinar Bengi Boz, Ayşe Filiz Koç, Muhammed Burak Bereketoğlu
Zitieren
APA
Boz, P. B., Koç, A. F., & Bereketoğlu, M. B. (2025). A triple A syndrome with neurological findings; c464G>A mutation in the AAAS gene. Ideggyógyászati szemle. https://doi.org/10.18071/isz.78.0207
Vancouver
Boz PB, Koç AF, Bereketoğlu MB. A triple A syndrome with neurological findings; c464G>A mutation in the AAAS gene. Ideggyógyászati szemle. 2025. doi:10.18071/isz.78.0207
BibTeX
@article{Boz2025,
author = {Boz, Pinar Bengi and Koç, Ayşe Filiz and Bereketoğlu, Muhammed Burak},
title = {A triple A syndrome with neurological findings; c464G>A mutation in the AAAS gene},
journal = {Ideggyógyászati szemle},
year = {2025},
doi = {10.18071/isz.78.0207}
}
EUVIMED